A Study to Learn About the Vepdegestrant (ARV-471, PF-07850327) in People With ER+/HER2- Locally Advanced or Metastatic Breast Cancer (BC)
Clinical trial NCT05463952 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05463952
- Sponsor
- Pfizer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-16
- Primary completion
- 2023-05-04
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.